Segmentation by type classifies implants according to material composition and functional architecture, offering insight into technology diffusion within the market. Synthetic polymer implants (e.g., polyurethanes, polyesters) represent the largest share, valued for their elasticity, ease of sterilization, and cost‑effectiveness, and they support a broad spectrum of tear morphologies. Biologic scaffold implants, derived from collagen or decellularized extracellular matrix, occupy a smaller but premium niche, leveraging inherent biocompatibility and potential for tissue integration, which justifies higher unit costs. Hybrid composite implants blend synthetic frameworks with biologic coatings, aiming to combine mechanical resilience with enhanced healing responses; this emerging category is gaining traction in high‑performance orthopedic centers. The distribution across these types directly impacts R&D investment, pricing dynamics, and reimbursement pathways, thereby shaping the total addressable market for meniscal repair solutions.